Electromed (ELMD) Shareholder's Equity Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.74% |
| Dec 31, 2025 | 6.69% |
| Sep 30, 2025 | 7.72% |
| Jun 30, 2025 | 7.39% |
| Mar 31, 2025 | 8.42% |
| Dec 31, 2024 | 8.91% |
| Sep 30, 2024 | 8.99% |
| Jun 30, 2024 | 11.60% |
| Mar 31, 2024 | 11.72% |
| Dec 31, 2023 | 11.13% |
| Sep 30, 2023 | 10.67% |
| Jun 30, 2023 | 10.78% |
| Mar 31, 2023 | 11.23% |
| Dec 31, 2022 | 11.28% |
| Sep 30, 2022 | 11.17% |
| Jun 30, 2022 | 11.50% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | 14.22% |
| Sep 30, 2021 | 14.68% |
| Jun 30, 2021 | 14.66% |
| Mar 31, 2021 | 15.18% |
| Dec 31, 2020 | 16.31% |
| Sep 30, 2020 | 16.62% |
| Jun 30, 2020 | 16.79% |
| Mar 31, 2020 | 16.55% |
| Dec 31, 2019 | 15.98% |
| Sep 30, 2019 | 15.52% |
| Jun 30, 2019 | 15.13% |
| Mar 31, 2019 | 14.50% |
| Dec 31, 2018 | 12.15% |
| Sep 30, 2018 | 11.05% |
| Jun 30, 2018 | 10.15% |
| Mar 31, 2018 | 8.37% |
| Dec 31, 2017 | 7.13% |
| Sep 30, 2017 | 5.96% |
| Jun 30, 2017 | 5.63% |
| Mar 31, 2017 | 3.43% |
| Dec 31, 2016 | 2.72% |
| Sep 30, 2016 | 2.11% |
| Jun 30, 2016 | 2.15% |